GlassScriptPhysician profile
Margaret Kelley
NPI 1932197910
$2,141.10
in general payments reported to CMS, 2019-2025
18 companies · $484 in 2025
The $484 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $301 · 2021: $204 · 2022: $231 · 2023: $247 · 2024: $336 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $467 · Education: $424 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.18 |
| Education | $424.42 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $421.98 | 2024-2025 | |
| Astellas Pharma US INC | $309.40 | 2020-2024 | Veozah, Myrbetriq |
| Pfizer INC. | $278.58 | 2019-2023 | |
| Abbvie INC. | $270.83 | 2019-2022 | |
| Amgen INC. | $175.00 | 2025 | Prolia |
| Mayne Pharma Commercial LLC | $164.44 | 2023-2025 | |
| Therapeuticsmd, INC. | $135.41 | 2019-2022 | |
| Hologic Sales and Service, LLC | $132.37 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $55.04 | 2019-2024 | Kristalose |
| Sumitomo Pharma America, INC. | $43.65 | 2024-2025 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $30.74 | 2019-2020 | |
| Shield Therapeutics INC | $22.63 | 2023 | Accrufer |
| Lupin INC. | $20.65 | 2020 | |
| Mission Pharmacal Company | $19.23 | 2021 | |
| Duchesnay USA Incorporated | $17.38 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $16.91 | 2022 | |
| Roche Diagnostics Corporation | $13.52 | 2019 | |
| Coopersurgical, INC. | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.